Apyx Medical Corporation (APYX) Investor Relations Documents

Apyx Medical Corporation (APYX) investor relations documents from the company's IR site: 2 presentations, 33 press releases; latest deck 2026-05-26. Read in-app with summaries. First-party data.

https://apyxmedical.com/wp-content/uploads/2026/05/Apyx-Medical-IR-Deck_May-2026.pdf — Apyx Medical is a surgical aesthetics company leveraging its Renuvion and AYON platforms to address the growing demand for skin tightening post-weight loss.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releaseApyx Medical Corporation Reports Second Quarter 2026 Financial Results
2026-07-28Press releaseApyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-05-27Press releaseBody by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway
2026-05-26Presentationhttps://apyxmedical.com/wp-content/uploads/2026/05/Apyx-Medical-IR-Deck_May-2026.pdf
2026-05-21Press releaseNew Study Shows Significant Improvement in Cellulite and Skin Laxity With Advanced Minimally Invasive Treatment Utilizin
2026-05-14Press releaseApyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in C
2026-05-11Press releaseApyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contour
2026-05-07Press releaseApyx Medical Corporation Reports First Quarter 2026 Financial Results
2026-04-23Press releaseApyx Medical Corporation To Release First Quarter Of Fiscal Year 2026 Financial Results On May 7, 2026
2026-04-01Press releaseRenuvion Wins 2026 NewBeauty Award For “Best Minimally Invasive Skin Tightner”
2026-03-10Press releaseApyx Medical Corporation Reports Fourth Quarter And Full Year 2025 Financial Results
2026-02-25Press releaseApyx Medical Corporation To Release Fourth Quarter Of Fiscal Year 2025 Financial Results On March 10, 2026
2026-02-23Presentationhttps://apyxmedical.com/wp-content/uploads/2026/02/Apyx-Medical-IR-Deck_JPM-2026.pdf
2026-02-18Press releaseApyx Medical Corporation To Participate In The Citizens Life Sciences Conference
2026-01-29Press releaseApyx Medical Corporation To Participate At The BTIG 13th Annual Medtech, Digital Health, Life Science & Diagnostic Tools
2026-01-12Press releaseApyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results
2025-12-03Press releaseApyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosm
2025-10-13Press releaseApyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuc
2025-09-29Press releaseApyx Medical To Host Virtual Key Opinion Leader Event To Discuss The Commercial Launch Of The Ayon Body Contouring Syste
2025-08-07Press releaseApyx Medical Expands Global Sales Leadership With Strategic Hires To Support Ayon Launch And Accelerated Growth
2025-08-07Press releaseApyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
2025-07-30Press releaseApyx Medical Corporation To Participate In The Canaccord Genuity 45th Annual Growth Conference
2025-07-28Press releaseApyx Medical Corporation Announces Launch Of Renuvion® In China
2025-07-24Press releaseApyx Medical Corporation To Release Second Quarter Of Fiscal Year 2025 Financial Results On August 7, 2025
2025-05-13Press releaseApyx Medical Corporation Receives Fda Clearance For The Ayon Body Contouring System™
2025-04-29Press releaseApyx Medical Corporation Announces Two Peer-reviewed Publications On The Use Of Renuvion In Abdominal Body Contouring Pr
2025-04-24Press releaseApyx Medical Corporation To Release First Quarter Of Fiscal Year 2025 Financial Results On May 8, 2025
2025-02-27Press releaseAPYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON MARCH 13, 2025
2025-01-06Press releaseAPYX MEDICAL CORPORATION SUBMITS 510(K) PREMARKET NOTIFICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE AYON BOD
2024-11-08Press releaseAPYX MEDICAL CORPORATION ANNOUNCES $7,000,000 MILLION REGISTERED DIRECT OFFERING
2024-11-08Press releaseApyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Intr
2024-10-25Press releaseAPYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024
2024-08-08Press releaseAPYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION COMPARING THE USE OF RENUVION TO A COMPETING TECH
2024-08-08Press releaseAPYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK
2024-07-25Press releaseAPYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON AUGUST 8, 2024

APYX overview · APYX earnings · APYX financials · APYX KPIs · APYX ownership · APYX peers · APYX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.